Form 4: Henry Schein Executive Sells Shares Under 10b5-1 Trading Plan

Michael S. Ettinger, EVP & Chief Operating Officer of Henry Schein, Inc., sold 12,240 shares of common stock at $75 per share under a pre-arranged 10b5-1 trading plan.

Summary

• Michael S. Ettinger, the Executive Vice President and Chief Operating Officer of Henry Schein, Inc., sold 12,240 shares of the company's common stock.
• The sale occurred on November 18, 2024, at a price of $75 per share.
• This transaction was executed under a Rule 10b5-1 trading plan adopted by Mr. Ettinger on March 4, 2024.
• Following the transaction, Mr. Ettinger directly owns 87,706 shares of Henry Schein common stock.
• He also indirectly owns 800 shares as trustee for his children's trusts and 210 shares through the company's 401(k) plan.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing related to an executive's stock sale under a pre-arranged plan. It does not indicate any positive or negative sentiment about the company's performance.

Industry Context

This is a routine filing related to insider trading activity and is common for executives of publicly traded companies. The use of a 10b5-1 plan indicates the sale was pre-planned and not based on any non-public information.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, and this filing is consistent with those requirements.
• The use of a 10b5-1 trading plan is a common method for executives to sell shares without raising concerns about insider trading, and is used by executives at companies such as Medtronic, Stryker, and Danaher.

Stakeholder Impact

• The stock sale by an executive may have a minor impact on shareholder sentiment, but the pre-planned nature of the sale mitigates any significant concerns.

Key Dates

Keywords

Form 4, insider trading, Rule 10b5-1, Henry Schein, HSIC, stock sale, executive, Michael S. Ettinger